- Home
- Labeler Index
- Catalent Pharma Solutions, Llc
- 11014-0449
- NDC Crossover: 11014-0449 Ruxolitinib
NDC Crossover 11014-0449 Ruxolitinib
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Ruxolitinib
Explore similar products and medications to NDC 11014-0449 Ruxolitinib drug for further processing with other products crossover matching the same product name (Ruxolitinib) or generic name (Ruxolitinib), and the same administration route () or dosage form (tablet). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 50881-005 | Jakafi | Ruxolitinib | Tablet | Oral | Incyte Corporation | Human Prescription Drug |
| 50881-010 | Jakafi | Ruxolitinib | Tablet | Oral | Incyte Corporation | Human Prescription Drug |
| 50881-015 | Jakafi | Ruxolitinib | Tablet | Oral | Incyte Corporation | Human Prescription Drug |
| 50881-020 | Jakafi | Ruxolitinib | Tablet | Oral | Incyte Corporation | Human Prescription Drug |
| 50881-025 | Jakafi | Ruxolitinib | Tablet | Oral | Incyte Corporation | Human Prescription Drug |